Literature DB >> 17105864

Successful treatment of cerebral vasculitis in an HIV-positive patient with anti-CD25 treatment.

C M G Nieuwhof, J Damoiseaux, J W Cohen Tervaert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17105864      PMCID： PMC1798457          DOI： 10.1136/ard.2005.044867

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  10 in total

1.  Alpha-CD25 antibody treatment in a child with hemophagocytic lymphohistiocytosis.

Authors:  Maren Tomaske; Oliver Amon; Axel Bosk; Rupert Handgretinger; E Marion Schneider; Dietrich Niethammer
Journal:  Med Pediatr Oncol       Date:  2002-02

2.  Cerebral vasculitis after initiation antiretroviral therapy.

Authors:  Andre J van der Ven; Robert J van Oostenbrugge; Bela Kubat; Jan Willem Tervaert
Journal:  AIDS       Date:  2002-11-22       Impact factor: 4.177

3.  A novel therapeutic option in pemphigus vulgaris: humanized monoclonal anti-CD25 antibody.

Authors:  A Renkl; M Mockenhaupt; K Technau; Y Herouy; J Norgauer
Journal:  Br J Dermatol       Date:  2004-06       Impact factor: 9.302

4.  Reconstitution of CD4+ T cell responses in HIV-1 infected individuals initiating highly active antiretroviral therapy (HAART) is associated with renewed interleukin-2 production and responsiveness.

Authors:  G A D Hardy; N Imami; A K Sullivan; A Pires; C T Burton; M R Nelson; B G Gazzard; F M Gotch
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

5.  Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.

Authors:  S Sakaguchi; N Sakaguchi; M Asano; M Itoh; M Toda
Journal:  J Immunol       Date:  1995-08-01       Impact factor: 5.422

6.  Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease.

Authors:  D Przepiorka; N A Kernan; C Ippoliti; E B Papadopoulos; S Giralt; I Khouri; J G Lu; J Gajewski; A Durett; K Cleary; R Champlin; B S Andersson; S Light
Journal:  Blood       Date:  2000-01-01       Impact factor: 22.113

7.  A pilot study on the use of the humanized anti-interleukin-2 receptor antibody daclizumab in active ulcerative colitis.

Authors:  Gert Van Assche; Ignace Dalle; Maja Noman; Isolde Aerden; Caroline Swijsen; Katrien Asnong; Bart Maes; Jan Ceuppens; Karel Geboes; Paul Rutgeerts
Journal:  Am J Gastroenterol       Date:  2003-02       Impact factor: 10.864

8.  Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration.

Authors:  Robert B Nussenblatt; Darby J S Thompson; Zhuqing Li; Chi Chao Chan; Jan S Peterson; Randy R Robinson; Richard S Shames; Sudha Nagarajan; Meina Tao Tang; Michelle Mailman; Gisela Velez; Chandra Roy; Grace A Levy-Clarke; Eric B Suhler; Ali Djalilian; Hatice Nida Sen; Shadi Al-Khatib; Roxana Ursea; Sunil Srivastava; Allison Bamji; Susan Mellow; Pushpa Sran; Thomas A Waldmann; Ronald R Buggage
Journal:  J Autoimmun       Date:  2003-11       Impact factor: 7.094

Review 9.  Primary (granulomatous) angiitis of the central nervous system: a clinicopathologic analysis of 15 new cases and a review of the literature.

Authors:  J T Lie
Journal:  Hum Pathol       Date:  1992-02       Impact factor: 3.466

10.  Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon beta.

Authors:  Bibiana Bielekova; Nancy Richert; Thomas Howard; Gregg Blevins; Silva Markovic-Plese; Jennifer McCartin; Joseph A Frank; Jens Würfel; Joan Ohayon; Thomas A Waldmann; Henry F McFarland; Roland Martin
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-25       Impact factor: 11.205
  10 in total
  6 in total

1.  Changes in peripheral CD4+CD25(high) regulatory T cells in the acute-on-chronic liver failure patients with plasma exchange treatment.

Authors:  Wei-lin Mao; Yu-Feng Lou; Bo Ye; Sha Lin; Yue-mei Chen; Yu Chen
Journal:  Inflammation       Date:  2012-04       Impact factor: 4.092

Review 2.  T cells in ANCA-associated vasculitis: what can we learn from lesional versus circulating T cells?

Authors:  Benjamin Wilde; Marielle Thewissen; Jan Damoiseaux; Pieter van Paassen; Oliver Witzke; Jan Willem Cohen Tervaert
Journal:  Arthritis Res Ther       Date:  2010-02-24       Impact factor: 5.156

Review 3.  HIV infection and clinical spectrum of associated vasculitides.

Authors:  Nirupa Patel; Neema Patel; Tahir Khan; Neej Patel; Luis R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2011-12       Impact factor: 4.686

Review 4.  HIV-associated large-vessel vasculopathy: a review of the current and emerging clinicopathological spectrum in vascular surgical practice.

Authors:  Balasoobramanien Pillay; Pratistadevi K Ramdial; Datshana P Naidoo
Journal:  Cardiovasc J Afr       Date:  2015 Mar-Apr       Impact factor: 1.167

5.  Response of Human Immunodeficiency Virus-Associated Cerebral Angiitis to the Combined Antiretroviral Therapy.

Authors:  Julian Cheron; Chloé Wyndham-Thomas; Niloufar Sadeghi; Gilles Naeije
Journal:  Front Neurol       Date:  2017-03-13       Impact factor: 4.003

Review 6.  Diffuse connective tissue disorders in HIV-infected patients.

Authors:  Anna Christoforidou; Nikolaos Galanopoulos
Journal:  Mediterr J Rheumatol       Date:  2018-09-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.